Trial Outcomes & Findings for An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia (NCT NCT02199717)
NCT ID: NCT02199717
Last Updated: 2016-12-14
Results Overview
To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.
COMPLETED
66 participants
7 days
2016-12-14
Participant Flow
Participant milestones
| Measure |
Boys With Hemophilia
Use of accelerometer for 1 week
|
|---|---|
|
Overall Study
STARTED
|
66
|
|
Overall Study
COMPLETED
|
66
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
BMI was grouped by hemophilia severity.
Baseline characteristics by cohort
| Measure |
Boys With Hemophilia
n=66 Participants
|
|---|---|
|
Age, Customized
<=18 years
|
66 participants
n=66 Participants
|
|
Age, Customized
Between 18 and 65 years
|
0 participants
n=66 Participants
|
|
Age, Customized
>=65 years
|
0 participants
n=66 Participants
|
|
Sex/Gender, Customized
Female
|
0 Participants
n=66 Participants
|
|
Sex/Gender, Customized
Male
|
66 Participants
n=66 Participants
|
|
Region of Enrollment
Canada
|
66 participants
n=66 Participants
|
|
BMI
Severe Hemophilia
|
20.05 kg/m2
STANDARD_DEVIATION 5.82 • n=42 Participants • BMI was grouped by hemophilia severity.
|
|
BMI
Mild/Moderate Hemophilia
|
21.93 kg/m2
STANDARD_DEVIATION 5.34 • n=24 Participants • BMI was grouped by hemophilia severity.
|
|
On demand or Prophylaxis Regimen
Severe Hemophilia · On prophylaxis
|
42 Participants
n=42 Participants • Grouped by hemophilia severity.
|
|
On demand or Prophylaxis Regimen
Severe Hemophilia · On demand
|
0 Participants
n=42 Participants • Grouped by hemophilia severity.
|
|
On demand or Prophylaxis Regimen
Mild/Moderate Hemophilia · On prophylaxis
|
5 Participants
n=24 Participants • Grouped by hemophilia severity.
|
|
On demand or Prophylaxis Regimen
Mild/Moderate Hemophilia · On demand
|
19 Participants
n=24 Participants • Grouped by hemophilia severity.
|
|
Severity of Hemophilia
Severe
|
42 Participants
n=66 Participants
|
|
Severity of Hemophilia
Mild/Moderate
|
24 Participants
n=66 Participants
|
PRIMARY outcome
Timeframe: 7 daysPopulation: All statistical analyses were completed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics such as mean (± SD) and range were calculated and provided for demographic variables, accelerometry variables and questionnaire outcomes. Differences between the two groups were examined in exploratory analyses.
To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.
Outcome measures
| Measure |
Severe Hemophilia
n=42 Participants
Severe Hemophilia
|
Mild/Moderate Hemophilia
n=24 Participants
Mild/Moderate Hemophilia
|
|---|---|---|
|
MVPA
|
48 minutes per day
Standard Deviation 20
|
55 minutes per day
Standard Deviation 18
|
PRIMARY outcome
Timeframe: 7 daysPopulation: All statistical analyses were completed using SAS 9.4 (SAS Institute Inc., Cary, NC, USA). Descriptive statistics such as mean (± SD) and range were calculated and provided for demographic variables, accelerometry variables and questionnaire outcomes. Differences between the two groups were examined in exploratory analyses.
To determine if the amount of time spent in sedentary time on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.
Outcome measures
| Measure |
Severe Hemophilia
n=42 Participants
Severe Hemophilia
|
Mild/Moderate Hemophilia
n=24 Participants
Mild/Moderate Hemophilia
|
|---|---|---|
|
Sedentary Time
|
633.4 minutes per day
Standard Deviation 121.3
|
327 minutes per day
Standard Deviation 78.73
|
Adverse Events
Severe Hemophilia
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place